<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[Genmab - Janssen er helt oppe på mærkerne]]></title><description><![CDATA[<p dir="auto">En opdatering fra Market Realist efter godkendelsen af Daratumumab:</p>
<p dir="auto"><a href="http://marketrealist.com/2015/11/market-response-fda-approval-darzalex/" rel="nofollow ugc">http://marketrealist.com/2015/11/market-response-fda-approval-darzalex/</a></p>
]]></description><link>https://dev.proinvestor.com/forum/topic/439093/genmab-janssen-er-helt-oppe-p-mrkerne</link><generator>RSS for Node</generator><lastBuildDate>Tue, 21 Jul 2026 22:06:46 GMT</lastBuildDate><atom:link href="https://dev.proinvestor.com/forum/topic/439093.rss" rel="self" type="application/rss+xml"/><pubDate>Fri, 20 Nov 2015 05:23:20 GMT</pubDate><ttl>60</ttl></channel></rss>